Research from Impact Analytics reveals size small for women is now the most popular size on Manhattan’s Upper East Side.
weight loss drugs like Ozempic and Wegovy, including direct impacts on the buying and allocation processes. Experts suggest companies that are not prepared will see increased lost sales due to stockouts and excess inventory with a significant impact on profitability.is leading in GLP-1 drug usage, with a reported 43.8 percent of the city’s GLP-1 drug prescriptions going to users who have not received a Type 2 diabetes diagnosis. These users are predominantly younger and 74.7 percent are female.
“Most retailers have clung to the same size curves for years despite evidence suggesting their inaccuracy,” Agrawal said. “The impact of that will continue to erode retailer margin integrity unless immediate action is taken to update them.” However, while the potentially significant shift in size allocation poses challenges to brands and retailers, Impact Analytics’ team also said there is an opportunity to engage with consumers. As consumers lose weight, data shows that they have been participating in some revenge shopping, taking the time to purchase an entirely new wardrobe and driving a surge in clothing sales. The company noted that for those retailers prepared to adapt, it can be a “golden opportunity.
With no signs of weight loss drug use slowing down, analysts from Impact Analytics suggest companies examine the efficacy of their current size curves, gain an understanding of how products and consumer segments intersect with the drug’s usage, plan for upcoming seasons with new size curves and begin to automate size curves with weight loss drug use incorporated.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jesse Plemons Responds to Weight Loss Medication Rumors Surrounding His Weight LossJesse Plemons denies using Ozempic to shed pounds. He credits intermittent fasting for his quick weight loss.
Read more »
Cheaper Versions of Popular New Weight-Loss Drugs Are Being DevelopedAs the patents on various weight-loss drugs near expiration, companies in India and China are vying to make lower-cost versions that will widen access to such treatments
Read more »
WHO issues rare warning on circulation of fake weight loss drugsPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines. WHO said Thursday that it has fielded reports of fake semaglutide _ the active ingredient in Novo Nordisk’s Wegovy and Ozempic.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.
Read more »